PATENT CLAIM ANALYSIS

Application Number: 16155861
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["514", "275000"]

Abstract:
The present disclosure relates to a 2,4-disubstituted pyrimidine derivative and the use thereof as a therapeutically effective cyclin-dependent kinase (CDK) inhibitor. In particular, the present disclosure relates to the use of a new 2,4-disubstituted pyrimidine derivatives shown in formula (I) and a pharmaceutical composition thereof as a selective CDK4/6 inhibitor in preventing or treating diseases related to CDK4/6.

Claim (Index 4):
The 2,4-disubstituted pyrimidine derivative according to  claim 1 , wherein the derivative is a compound selected from the group consisting of: Compound Structure I-1    I-2    I-3    I-4    I-6    I-7    I-8    I-9    I-10    I-11    I-14    I-15    I-16    I-17    I-18    I-19    I-20    I-21    I-22    I-23    I-24    I-25    I-26    I-27    I-28    I-32    I-33    I-34    I-35    I-36    I-37    I-38    I-39    I-40    I-41    I-42    I-47    I-48  or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.54762
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16155867', '15764884', '15328813', '12843494', '11690305']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7765992918130166
- 35 USC 102 Novelty (BERT): 0.5256687959740403
- Combined Prediction Score: 0.751506242229119
- Mean Citation Score: 279.08915
- Max Citation Score: 322.41934
- Similarity Product: 241.8903764410257

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test